Enterprise Value
-55.31M
Cash
107.9M
Avg Qtr Burn
-23.17M
Short % of Float
4.67%
Insider Ownership
2.30%
Institutional Own.
58.01%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EO-3021 Details Solid tumor/s | Phase 1 Data readout |